| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |